Table of Contents

August 2017, Volume 24, Number 8

Review

    • Sangeeta Kumari,
    • Dhirodatta Senapati,
    • and Hannelore V Heemers

    Rationale for the development of alternative forms of androgen deprivation therapy

    Endocr Relat Cancer 24 (8) R275-R295, doi:10.1530/ERC-17-0121 first published on 31 May 2017
    • Nicholas Russell,
    • Ada Cheung,
    • and Mathis Grossmann

    Estradiol for the mitigation of adverse effects of androgen deprivation therapy

    Endocr Relat Cancer 24 (8) R297-R313, doi:10.1530/ERC-17-0153 first published on 30 June 2017

Research

    • Laura C Hernández-Ramírez,
    • Ryhem Gam,
    • Nuria Valdés,
    • Maya B Lodish,
    • Nathan Pankratz,
    • Aurelio Balsalobre,
    • Yves Gauthier,
    • Fabio R Faucz,
    • Giampaolo Trivellin,
    • Prashant Chittiboina,
    • John Lane,
    • Denise M Kay,
    • Aggeliki Dimopoulos,
    • Stephan Gaillard,
    • Mario Neou,
    • Jérôme Bertherat,
    • Guillaume Assié,
    • Chiara Villa,
    • James L Mills,
    • Jacques Drouin,
    • and Constantine A Stratakis

    Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease

    Endocr Relat Cancer 24 (8) 379-392, doi:10.1530/ERC-17-0131 first published on 22 May 2017
    OPEN ACCESS ARTICLE
    • Tianzhu Zang,
    • Mary-Ellen Taplin,
    • Daniel Tamae,
    • Wanling Xie,
    • Clementina Mesaros,
    • Zhenwei Zhang,
    • Glenn Bubley,
    • Bruce Montgomery,
    • Steven P Balk,
    • Elahe A Mostaghel,
    • Ian A Blair,
    • and Trevor M Penning

    Testicular vs adrenal sources of hydroxy-androgens in prostate cancer

    Endocr Relat Cancer 24 (8) 393-404, doi:10.1530/ERC-17-0107 first published on 29 June 2017
    • Roberto Valente,
    • Alastair J Hayes,
    • Sven-Petter Haugvik,
    • Per Hedenström,
    • Darko Siuka,
    • Emilie Korsæth,
    • Daniel Kämmerer,
    • Stuart M Robinson,
    • Patrick Maisonneuve,
    • Gianfranco Delle Fave,
    • Bjorn Lindkvist,
    • and Gabriele Capurso

    Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms

    Endocr Relat Cancer 24 (8) 405-414, doi:10.1530/ERC-17-0040 first published on 31 May 2017
    • Praveena S Thiagarajan,
    • Qiao Zheng,
    • Manvir Bhagrath,
    • Erin E Mulkearns-Hubert,
    • Martin G Myers,
    • Justin D Lathia,
    • and Ofer Reizes

    STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance

    Endocr Relat Cancer 24 (8) 415-426, doi:10.1530/ERC-16-0349
    • Jan P Dumanski,
    • Chiara Rasi,
    • Peyman Björklund,
    • Hanna Davies,
    • Abir S Ali,
    • Malin Grönberg,
    • Staffan Welin,
    • Halfdan Sorbye,
    • Henning Grønbæk,
    • Janet L Cunningham,
    • Lars A Forsberg,
    • Lars Lind,
    • Erik Ingelsson,
    • Peter Stålberg,
    • Per Hellman,
    • and Eva Tiensuu Janson

    A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

    Endocr Relat Cancer 24 (8) 427-443, doi:10.1530/ERC-17-0196 first published on 20 June 2017
    OPEN ACCESS ARTICLE
    • R Formosa,
    • J Borg,
    • and J Vassallo

    Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas

    Endocr Relat Cancer 24 (8) 445-457, doi:10.1530/ERC-17-0112 first published on 25 June 2017
    OPEN ACCESS ARTICLE

Research Letter

    • L Fishbein,
    • S Ben-Maimon,
    • S Keefe,
    • K Cengel,
    • D A Pryma,
    • A Loaiza-Bonilla,
    • D L Fraker,
    • K L Nathanson,
    • and D L Cohen

    SDHB mutation carriers with malignant pheochromocytoma respond better to CVD

    Endocr Relat Cancer 24 (8) L51-L55, doi:10.1530/ERC-17-0086 first published on 31 May 2017
    • Lucie Evenepoel,
    • Raphaël Helaers,
    • Laurent Vroonen,
    • Selda Aydin,
    • Marc Hamoir,
    • Dominique Maiter,
    • Miikka Vikkula,
    • and Alexandre Persu

    KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors

    Endocr Relat Cancer 24 (8) L57-L61, doi:10.1530/ERC-17-0061 first published on 17 May 2017
    • Frederic Castinetti,
    • Ana Luiza Maia,
    • Mariola Peczkowska,
    • Marta Barontini,
    • Kornelia Hasse-Lazar,
    • Thera P Links,
    • Rodrigo A Toledo,
    • Sarka Dvorakova,
    • Caterina Mian,
    • Maria Joao Bugalho,
    • Stefania Zovato,
    • Maria Alevizaki,
    • Andrei Kvachenyuk,
    • Birke Bausch,
    • Paola Loli,
    • Simona R Bergmann,
    • Attila Patocs,
    • Marija Pfeifer,
    • Josefina Biarnes Costa,
    • Ernst von Dobschuetz,
    • Claudio Letizia,
    • Gerlof Valk,
    • Marcin Barczynski,
    • Malgorzata Czetwertynska,
    • John T M Plukker,
    • Paola Sartorato,
    • Tomas Zelinka,
    • Petr Vlcek,
    • Svetlana Yaremchuk,
    • Georges Weryha,
    • Letizia Canu,
    • Nelson Wohllk,
    • Frederic Sebag,
    • Martin K Walz,
    • Charis Eng,
    • and Hartmut P H Neumann

    The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations

    Endocr Relat Cancer 24 (8) L63-L67, doi:10.1530/ERC-17-0189 first published on 25 June 2017

Letter to the Editor

    • Ruth T Casey,
    • Benjamin G Challis,
    • Alison Marker,
    • Deborah Pitfield,
    • Heok K Cheow,
    • Ashley Shaw,
    • Soo-Mi Park,
    • Helen L Simpson,
    • and Eamonn R Maher

    A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery

    Endocr Relat Cancer 24 (8) L69-L71, doi:10.1530/ERC-17-0206
    OPEN ACCESS ARTICLE
|

This Issue

August 2017; 24 (8)
Cover
  1. Review
  2. Research
  3. Research Letter
  4. Letter to the Editor

Find articles in this issue containing these words:

New Articles: issue in progress

  1. April 2018, 25 (4)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most